FEMSTAT One

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved Februrary 1997

Specific Treatments:

vaginal yeast infections

Find Related Trials for The Following Conditions

General Information

FEMSTAT One has been approved for the treatment of vulvovaginal infections caused by Candida albicans.